A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.
Clinical trial NCT06143891 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06143891
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-23
- Primary completion
- 2028-09-29
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.